AKRO logo

Akero Therapeutics, Inc. (AKRO) Selling, general & administrative expenses

annual SGA:

$0.00-$31.07M(-100.00%)
December 31, 2024

Summary

  • As of today (September 16, 2025), AKRO annual SGA is $0.00, with the most recent change of -$31.07 million (-100.00%) on December 31, 2024.
  • During the last 3 years, AKRO annual SGA has fallen by -$19.13 million (-100.00%).
  • AKRO annual SGA is now -100.00% below its all-time high of $31.07 million, reached on December 31, 2023.

Performance

AKRO SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

quarterly SGA:

$0.00-$11.31M(-100.00%)
June 30, 2025

Summary

  • As of today (September 16, 2025), AKRO quarterly SGA is $0.00, with the most recent change of -$11.31 million (-100.00%) on June 30, 2025.
  • Over the past year, AKRO quarterly SGA has dropped by -$10.42 million (-100.00%).
  • AKRO quarterly SGA is now -100.00% below its all-time high of $11.31 million, reached on March 31, 2025.

Performance

AKRO quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

TTM SGA:

-$3.45B-$283.96M(-8.98%)
June 30, 2025

Summary

  • As of today (September 16, 2025), AKRO TTM SGA is -$3.45 billion, with the most recent change of -$283.96 million (-8.98%) on June 30, 2025.
  • Over the past year, AKRO TTM SGA has dropped by -$3.48 billion (-9624.82%).
  • AKRO TTM SGA is now -75416.10% below its all-time high of -$4.56 million.

Performance

AKRO TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

AKRO Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-9624.8%
3 y3 years-100.0%-100.0%-10000.0%
5 y5 years-100.0%-100.0%-10000.0%

AKRO Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%at low-167.5%at low
5 y5-year-100.0%at low-100.0%at low-531.6%at low
alltimeall time-100.0%at low-100.0%at low<-9999.0%at low

AKRO Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$20.79M(-33.4%)
Mar 2025
-
$11.31M(>+9900.0%)
$31.20M(+6.9%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$29.19M(-22.5%)
Sep 2024
-
$9.47M(-9.1%)
$37.67M(+4.1%)
Jun 2024
-
$10.42M(+12.0%)
$36.19M(+8.3%)
Mar 2024
-
$9.30M(+9.7%)
$33.41M(+7.5%)
Dec 2023
$31.07M(+4.0%)
$8.48M(+6.3%)
$31.07M(+4.7%)
Sep 2023
-
$7.98M(+4.4%)
$29.69M(-9.2%)
Jun 2023
-
$7.64M(+9.7%)
$32.71M(+4.5%)
Mar 2023
-
$6.97M(-1.9%)
$31.30M(+4.8%)
Dec 2022
$29.87M(+56.2%)
$7.10M(-35.5%)
$29.87M(+8.6%)
Sep 2022
-
$11.00M(+76.6%)
$27.50M(+28.6%)
Jun 2022
-
$6.23M(+12.5%)
$21.38M(+6.2%)
Mar 2022
-
$5.54M(+17.1%)
$20.14M(+5.3%)
Dec 2021
$19.13M
$4.73M(-3.2%)
$19.13M(+3.5%)
Sep 2021
-
$4.88M(-2.1%)
$18.47M(+4.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
$4.99M(+10.3%)
$17.75M(+9.7%)
Mar 2021
-
$4.53M(+11.1%)
$16.18M(+6.2%)
Dec 2020
$15.24M(+77.1%)
$4.07M(-2.0%)
$15.24M(+7.0%)
Sep 2020
-
$4.16M(+21.7%)
$14.25M(+13.9%)
Jun 2020
-
$3.42M(-4.8%)
$12.51M(+16.5%)
Mar 2020
-
$3.59M(+16.4%)
$10.74M(+24.9%)
Dec 2019
$8.61M(+353.9%)
$3.08M(+27.2%)
$8.61M(+32.3%)
Sep 2019
-
$2.42M(+47.0%)
$6.51M(+42.8%)
Jun 2019
-
$1.65M(+13.8%)
$4.56M(+44.7%)
Mar 2019
-
$1.45M(+47.3%)
$3.15M(+66.1%)
Dec 2018
$1.90M(+75.9%)
$984.00K(+107.2%)
$1.90M(+73.3%)
Sep 2018
-
$475.00K(+96.3%)
$1.09M(+76.7%)
Jun 2018
-
$242.00K(+24.1%)
$619.00K(+64.2%)
Mar 2018
-
$195.00K(+7.1%)
$377.00K(+107.1%)
Dec 2017
$1.08M
-
-
Dec 2017
-
$182.00K
$182.00K

FAQ

  • What is Akero Therapeutics, Inc. annual SGA?
  • What is the all time high annual SGA for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. annual SGA year-on-year change?
  • What is Akero Therapeutics, Inc. quarterly SGA?
  • What is the all time high quarterly SGA for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. quarterly SGA year-on-year change?
  • What is Akero Therapeutics, Inc. TTM SGA?
  • What is the all time high TTM SGA for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. TTM SGA year-on-year change?

What is Akero Therapeutics, Inc. annual SGA?

The current annual SGA of AKRO is $0.00

What is the all time high annual SGA for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high annual SGA is $31.07M

What is Akero Therapeutics, Inc. annual SGA year-on-year change?

Over the past year, AKRO annual SGA has changed by -$31.07M (-100.00%)

What is Akero Therapeutics, Inc. quarterly SGA?

The current quarterly SGA of AKRO is $0.00

What is the all time high quarterly SGA for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high quarterly SGA is $11.31M

What is Akero Therapeutics, Inc. quarterly SGA year-on-year change?

Over the past year, AKRO quarterly SGA has changed by -$10.42M (-100.00%)

What is Akero Therapeutics, Inc. TTM SGA?

The current TTM SGA of AKRO is -$3.45B

What is the all time high TTM SGA for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high TTM SGA is -$4.56M

What is Akero Therapeutics, Inc. TTM SGA year-on-year change?

Over the past year, AKRO TTM SGA has changed by -$3.48B (-9624.82%)
On this page